多参数MRI评估可切除非小细胞肺癌新辅助化免疫治疗病理反应
本研究回顾性分析32例接受新辅助化免疫治疗的可切除非小细胞肺癌患者,于基线和治疗3周后行IVIM-DWI和DKI功能MRI。结果显示pCR组治疗后ADC、ΔADC、ΔD值显著高于非pCR组,而治疗前D、治疗后Kapp及ΔKapp显著低于非pCR组;治疗前D和治疗后Kapp为独立预测因子,联合模型AUC达0.889。
要点
- 治疗前D值低、治疗后Kapp值高提示非pCR,可用于早期识别疗效不佳者。
- pCR组治疗后ADC、D值升高更明显,ΔADC和ΔD可反映治疗反应。
- IVIM-DWI联合DKI模型预测病理反应AUC为0.889,有潜力指导个体化治疗。
关键影像表现/征象
- pCR组治疗后ADC、ΔADC和ΔD值显著高于非pCR组。
- pCR组治疗前D、治疗后Kapp和ΔKapp值显著低于非pCR组。
- 非pCR组残余肿瘤倾向于具有更高的微观结构复杂性和异质性,以Kapp衡量。
诊断标准与关键数值
- 多因素logistic回归显示治疗前D值和治疗后Kapp值为NCIT反应的独立预测因子。
- 由IVIM-DWI和DKI参数组合的联合预测模型预测性能最佳,AUC为0.889。
临床应用与阅片要点
- 基线D值较低、治疗后Kapp值较高的患者更可能非pCR,提示需早期调整治疗策略。
- 关注治疗后ADC和D值升高幅度,pCR者升高更显著。
局限性
- 回顾性分析,样本量仅32例,来自3项单臂临床试验。
- 功能MRI为探索性终点,需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study aimed to explore the predictive value of intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) and diffusion kurtosis imaging (DKI) quantitative parameters for the response to neoadjuvant chemo-immunotherapy (NCIT) in resectable non-small-cell lung cancer (NSCLC) patients, so as to provide a basis for clinical individualized precision treatment.
METHODS: Treatment naive locally advanced NSCLC patients who enrolled in 3 prospective, open-label, and single-arm clinical trials and received NCIT were retrospectively analyzed in this study. Functional MRI imaging was performed at baseline and following 3 weeks of treatment as an exploratory endpoint to evaluate treatment efficacy. Univariate and multivariate logistic regressions were used to identify independent predictive parameters for NCIT response. Prediction models were built with statistically significant quantitative parameters and their combinations.
RESULTS: In total of 32 patients, 13 were classified as complete pathological response (pCR) and 19 were non-pCR. Post-NCIT ADC, ΔADC, and ΔD values in the pCR group were significantly higher than those in the non-pCR group, while the pre-NCIT D, post-NCIT Kapp, and ΔKapp were significantly lower than those in non-pCR group. Multivariate logistic regression analysis demonstrated that pre-NCIT D and post-NCIT Kapp values were independent predictors for NCIT response. The combined predictive model, which consisted of IVIM-DWI and DKI, showed the best prediction performance with AUC of 0.889.
CONCLUSIONS: The pre-NCIT D, post-NCIT parameters (ADC and Kapp) and Δ parameters (ΔADC, ΔD, and ΔKapp) were effective biomarkers for predicting pathologic response, and pre-NCIT D and post-NCIT Kapp values were independent predictors of NCIT response for NSCLC patients.
CLINICAL RELEVANCE STATEMENT: This exploratory study indicated that IVIM-DWI and DKI MRI imaging would predict pathologic response of neoadjuvant chemo-immunotherapy in locally advanced NSCLC patients at initial state and early treatment, which could help make clinical individualized treatment strategies.
KEY POINTS: • Effective NCIT treatment resulted in increased ADC and D values for NSCLC patients. • The residual tumors in non-pCR group tend to have higher microstructural complexity and heterogeneity, as measured by Kapp. • Pre-NCIT D and post-NCIT Kapp values were independent predictors of NCIT response.
引用
- Bao, Bian, Yang, et al. Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer. Eur Radiol. 2023. PMID: 37382618. doi:10.1007/s00330-023-09813-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。